Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Methylnaltrexone for Ticagrelor Absorption in STEMI
NCT02942550Phase 4Completed
- Sponsor
- Karolinska University Hospital
- Start
- Nov 2016
- Primary completion
- Dec 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of methylnaltrexone in ST-segment elevation myocardial infarction (STEMI), sponsored by Karolinska University Hospital. Started Nov 2016; status: completed.
02
Drugs
methylnaltrexone
03
Conditions
ST-segment elevation myocardial infarction (STEMI)
Beyond the preview
Go deeper on NCT02942550.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02942550.